CXCR3 and neoplasm: Within TNBC specifically, harnessing or enhancing the CXCL9–CXCR3 interaction could potentially strengthen immune infiltration and cytotoxicity, laying the groundwork for novel immunotherapeutic strategies that boost anti-tumor immunity (28).